Surgical Intervention for Posthyperglycemic Hemiballismus: Illustrative Case and Literature Review

Read full text
Authors: Racheed M. Mani, Tiffany Kim, Thomas Kim, Chiemeka Uwakwe, Chuchu Zheng, Sima Mofakham, Eltonnelle James, Charles Mikell, Guy Schwartz
Cited by: 1
References: 22

Abstract

BACKGROUND: Hemiballismus/hemichorea can manifest as a systemic sequala of severe hyperglycemia. This typically resolves with optimal glycemic control supplemented by neuroleptic agents. However, in a subset of patients, this hyperkinetic movement disorder may persist despite maximal medical management. CASES: We present a 70-year-old man with type 2 diabetes mellitus (DM) who presented with 6 months of right-sided hemiballismus/hemichorea that started after a previous episode of nonketotic hyperglycemia. Despite optimal glucose control and the administration of several neuroleptic agents, his symptoms failed to resolve. He underwent left-sided deep brain stimulation (DBS) to the globus pallidus internus (GPi), with subsequent improvement in his hyperkinetic movements. LITERATURE REVIEW: We document 7 cases in the literature of posthyperglycemic chorea-ballism (PHGCB) treated with either pallidal or thalamic DBS or pallidotomy. The procedures were safe and well tolerated, and all patients demonstrated clinical improvement following surgery. CONCLUSION: PHGCB represents a rare but serious complication of DM. There is a subset of patients who fail to respond to maximal medical therapy. Our illustrative case and review demonstrate that these patients may benefit from neurosurgical intervention. Further studies with long-term follow-up are warranted to substantiate the value of surgical approaches for medically refractory diabetic striatopathy.

Fields of Study & Subjects

Neurological and metabolic disorders Neurological disorders and treatments Autoimmune Neurological Disorders and Treatments

Publication details

Journal / source
Movement Disorders Clinical Practice
Publisher
Wiley
Volume
13
Issue
10
Pages
2586-2593
Publication date
6 July 2026
Language
EN